Company Press Release

PHILADELPHIA, June 15, 2015 /PRNewswire/ -- Today, as thousands of drug makers interact at the 2015 BIO International Convention, Deloitte is releasing a report suggesting that biopharmaceutical companies could have greater success if they collaborate with other organizations – even competitors – as part of an open innovation approach to research and development.

PPD and HealthCore Collaborate to Deliver Enhanced Pre- and Post-approval Research Services

ByCompany Press Release

June 16th 2015

CRF Health Launches TrialMax ConMed™ Solution to Capture Concomitant Medication Data Directly from Patients

ByCompany Press Release

June 16th 2015

PRA Continues the Transformation of Clinical Trials with PredictivvTM

ByCompany Press Release

June 16th 2015

New Research Shows Clinical Operations Moving to Electronic Processes, Industry on the Path to the Paperless Trial

ByCompany Press Release

June 15th 2015

PatientsLikeMe and the FDA Sign Research Collaboration Agreement

ByCompany Press Release

June 15th 2015

BBK Worldwide Appoints New Managing Director of Japan, Toshio Mori, Opens Tokyo Office

ByCompany Press Release

June 15th 2015

Company Press Release

Articles by Company Press Release

Parexel Expands Model-Based Drug Development Offering

Certara Creates Preeminent Global Strategic Modeling and Simulation Consultancy

Sharp Clinical Services Expand Facilities In Crickhowell, UK

New Release of goBalto Activate Enhances Risk Management in Clinical Trials

Quintiles and Quest Diagnostics Launch Q2 Solutions

Rethink Research Competition Opens Voting for the People’s Choice Award

BioClinica Expands Operational Capabilities, Opens New European Offices

New Role for Twitter: Early Warning System for Bad Drug Interactions

Acorn Regulatory Streamlines Approval Process for U.S. Drug-Device Manufacturers

Japanese Biotech JCR Pharmaceuticals Selects Medidata’s Cloud-Based Platform to Power Rare Disease Clinical Research in Japan-ACT

WIRB-Copernicus Group Expands its Annual International Fellows Program to Include Ethics Training at New York University Langone Medical Center

Bracket Acquires Clintara In Move To Strengthen Rater Training, Quality Assurance, And Electronic Clinical Outcomes Assessment Capabilities

Society for Clinical Research Sites Welcomes Covance as its Newest Global Impact Partner

New Tufts CSDD Report Profiles New R&D Cross-Functional Approaches Driving Higher Levels of Efficiency

PAREXEL Launches Next Generation Data-Driven Monitoring Capabilities within Perceptive MyTrials® Solution

Oracle Expands Clinical Safety Monitoring and Reporting Capabilities with Oracle Argus 8.0 Solutions

Quintiles Introduces Infosario One Mobile App

Catalent Expands Packaging Capabilities in Singapore to Complement its Asia Pacific Clinical Supply Network

Medidata Completes Study Exploring Potential for Instrumenting Patients with Mobile Health Tools in a Clinical Trial Setting

Nextrials Presents to FDA on the Viability of Integrating Electronic Health Records for Improved Clinical Data and Drug Safety Reporting

Quintiles Unveils New Predictive and Advanced Analytics Capabilities to Enhance its Risk-Based Monitoring Solution

CluePoints Introduces Risk-Based Monitoring Software for Operational Data Analysis at DIA 2015

OmniComm Systems® Expands Presence in Japan and Philippines

Deloitte Report: Open R&D Models Increase Chances for Late-Stage Success

PPD and HealthCore Collaborate to Deliver Enhanced Pre- and Post-approval Research Services

CRF Health Launches TrialMax ConMed™ Solution to Capture Concomitant Medication Data Directly from Patients

PRA Continues the Transformation of Clinical Trials with PredictivvTM

New Research Shows Clinical Operations Moving to Electronic Processes, Industry on the Path to the Paperless Trial

PatientsLikeMe and the FDA Sign Research Collaboration Agreement

BBK Worldwide Appoints New Managing Director of Japan, Toshio Mori, Opens Tokyo Office

Trending on Applied Clinical Trials Online

Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity

Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg

FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results

ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research

ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation